The activation of AHR promotes obesity and IR [64], whereas impaired AHR leads to dietary- and genetic-mediated metabolic impairments, notably glucose dysmetabolism and liver steatosis [65,66]. Here, AHR is linked to obesity due to melanocortin 4 receptor deficiency.